Renal impairment is frequent in chronic hepatitis C patients under triple therapy with telaprevir or boceprevir

Hepatology. 2014 Jun;59(6):2426. doi: 10.1002/hep.26730. Epub 2014 Apr 14.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Female
  • Hepatitis C, Chronic / drug therapy*
  • Humans
  • Male
  • Oligopeptides / adverse effects*
  • Proline / analogs & derivatives*
  • Renal Insufficiency / chemically induced*

Substances

  • Oligopeptides
  • Proline